Reduced Birth Weight Caused by Sextuple Drug-Resistant Plasmodium falciparum Infection in Early Second Trimester.
Helle H HanssonDaniel T R MinjaSofie L MoellerJohn P A LusinguIb C BygbjergAnna-Mathilde YdeRasmus W JensenSidsel NagOmari A MsemoThor G TheanderMichael AlifrangisChristentze SchmiegelowPublished in: The Journal of infectious diseases (2022)
Mutations in the Plasmodium falciparum genes Pfdhfr and Pfdhps, particularly the sextuple mutant haplotype threatens the antimalarial effectiveness of sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment during pregnancy (IPTp). To explore the impact of sextuple mutant haplotype infections on outcome measures after provision of IPTp with SP, we monitored birth outcomes in women followed up from before conception or from the first trimester until delivery. Women infected with sextuple haplotypes, in the early second trimester specifically, delivered newborns with a lower birth weight compared with women who did not have malaria during pregnancy (difference, -267 g; 95% confidence interval, -454 to -59; P = .01) and women infected with less SP-resistant haplotypes (-461 g; -877 to -44; P = .03). Thus, sextuple haplotype infections seem to affect the effectiveness of SP for IPTp and directly affect birth outcome by lowering birth weight. Close monitoring and targeted malaria control during early pregnancy is therefore crucial to improving birth outcomes.
Keyphrases
- gestational age
- plasmodium falciparum
- birth weight
- preterm birth
- drug resistant
- polycystic ovary syndrome
- pregnancy outcomes
- weight gain
- randomized controlled trial
- systematic review
- cervical cancer screening
- pregnant women
- breast cancer risk
- acinetobacter baumannii
- palliative care
- low birth weight
- physical activity
- adipose tissue
- skeletal muscle
- combination therapy
- wild type